Victims: Thalidomide sold in Spain post-withdrawal

by Jorge Sainz

(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Gruenenthal withdrew thalidomide in 1961. It had been prescribed to pregnant women mostly to combat but led to a wave of birth defects in Europe, Australia, Canada and Japan. The company has refused to accept liability, but last year it apologized to victims and has set up a fund for German ones.

The Spanish Association of Thalidomide Victims released documents it said prove the distributor delivered thalidomide tablets to Spain until May 1962.

But Gruenenthal's vice-president for corporate affairs, Frank Schonrock, insisted in comments emailed to The Associated Press that his company pulled the drug in Spain at the same time as in Germany.

The Spanish victims intend to present the documents about the distribution of thalidomide tablets when its lawsuit against Gruenenthal begins at a Madrid court on Oct. 14, said Jose Riquelme, head of the association, which has about 200 members.

The association is asking for 208 million euros ($273 million) in compensation from the German manufacturer.

"We want to get back the dignity which the Germany pharmaceutical company took from us before we were born," Riquelme told a news conference in Madrid.

Last July, an Australian woman born without arms and legs after her mother took thalidomide reached a multimillion dollar settlement with the drug's British distributor. Gruenenthal refused to settle. The lawsuit was part of a class action, and more than 100 other survivors expect to have their claims heard this year.

is still sold today, but as a treatment for , a bone marrow cancer, and .

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Australian wins millions in Thalidomide lawsuit

Jul 18, 2012

(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Australian to lead thalidomide suit

Jun 25, 2011

An Australian woman born without arms and legs will lead a mass lawsuit against the German and British firms behind thalidomide, a sedative blamed for birth defects, lawyers said Saturday.

Australian woman wins thalidomide hearing: court

Dec 19, 2011

A woman born without arms or legs on Monday won the right to have the class action she is leading against the firms behind thalidomide, a sedative blamed for birth defects, proceed in Australia.

Thalidomide maker 'ignored birth defects for years'

Jul 27, 2012

The German makers of thalidomide were warned of birth defects years before it was withdrawn and Australian distributors used pregnant women as the world's first test subjects, court papers alleged Friday.

Recommended for you

Vaccine proves effective against deadly Middle East virus

17 hours ago

(Medical Xpress)—A vaccine developed by an international team of scientists led by the University of Pittsburgh School of Medicine successfully protects mice against a contagious and deadly virus spreading across the Middle ...

New study looks at improving vaccine awareness

18 hours ago

The best medical therapies won't do much good if the public abstains from using them. Resistance to life-saving interventions may have a variety of root causes, particularly if the biotechnology involved is new and poorly ...

High-dose opioid prescribing continues to climb

Sep 12, 2014

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new ...

Feds say Bayer colon supplement makes bogus claims

Sep 12, 2014

The United States government accused Bayer of making scientifically unproven statements about the health benefits of a popular probiotic on Friday, claiming the German pharmaceutical giant was in contempt of court.

User comments